KhaledElsayad
@DrKhaledElsayad
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members redjournal.org/video-do/real-…
📢Registration closes tomorrow at 4PM! Take part in the Joint Y-ECI CLTG and ROSC Webinar series focusing on Cutaneous T-cell lymphoma treatments and the role of recent low-dose radiotherapy on 12 December from 5PM - 5:45PM CET. 👉 Register: cm.eortc.org/cmPortal/Porta… #RADCUTIS
Congrats and 🙏 to @DrKhaledElsayad and #EORTC-CLTG colleagues on this intriguing & topical work exposing the heterogeneity in #RT for #cutaneouslymphomas Open access ➡️ redjournal.org/article/S0360-… @EORTC @IJROBP @MarioLevis82 @LenaSpecht1 @PeterMacCC @RANZCRcollege @ILROGTeam
💙 Art of Global Oncology: Dr. Elsayad describes their impressions regarding the medical and surgical procedures used for patients with cancer and reports on the oncological cases from ancient Egyptian remains published in the literature. ➡️ brnw.ch/21wC3NH
Y-ECI CLTG and Y-ECI ROSC Webinar Series eortc.org/event/y-eci-cl…
The Safety and Efficacy of the Combination of Sacituzumab Govitecan and Palliative Radiotherapy—A Retrospective Multi-Center Cohort Study mdpi.com/2764856 #mdpicancers via @Cancers_MDPI
Personalie: Dr. Khaled Elsayad, Oberarzt aus der UKM-Klinik für #Strahlentherapie – Radioonkologie, ist im Januar zum Sprecher der Arbeitsgruppe Dermatoonkologie der DEGRO (Deutsche Gesellschaft für Radioonkologie) gewählt worden. (1/3)